CLINICAL_TRIALS research · 2026-01-16

Clinical Trial Update: Dynamic 82-Rb Positron Emission Tomography (PET) for the Grading of KIDney Carcinoma [Phase 2]

This is a Phase 2 clinical trial evaluating dynamic 82-Rb PET imaging to grade renal cell carcinoma, with status listed as not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Renal Cell Carcinoma | Phase 2 | Status: NOT_YET_RECRUITING